Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to -$284000.0.

  • Eton Pharmaceuticals' Cash from Investing Activities changed N/A to -$284000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.4 million, marking a year-over-year decrease of 134584.12%. This contributed to the annual value of -$40.0 million for FY2024, which is 506309.68% down from last year.
  • Eton Pharmaceuticals' Cash from Investing Activities amounted to -$284000.0 in Q3 2025.
  • In the past 5 years, Eton Pharmaceuticals' Cash from Investing Activities registered a high of -$2000.0 during Q3 2021, and its lowest value of -$38.1 million during Q4 2024.
  • In the last 5 years, Eton Pharmaceuticals' Cash from Investing Activities had a median value of -$768000.0 in 2022 and averaged -$4.7 million.
  • Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Cash from Investing Activities showed a top increase of 9963.12% in 2022 and a maximum decrease of 9990000.0% in 2022.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Cash from Investing Activities stood at -$3.3 million in 2021, then skyrocketed by 99.63% to -$12000.0 in 2022, then plummeted by 6358.33% to -$775000.0 in 2023, then tumbled by 4820.26% to -$38.1 million in 2024, then skyrocketed by 99.26% to -$284000.0 in 2025.
  • Its Cash from Investing Activities stands at -$284000.0 for Q3 2025, versus -$38.1 million for Q4 2024 and -$1.9 million for Q1 2024.